Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the company's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the sale, the director now owns 35,609 shares in the company, valued at $2,349,837.91. This trade represents a 49.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Nicholas Dominic Cortezi also recently made the following trade(s):
Shares of RYAN stock traded down $0.12 on Wednesday, hitting $66.20. The stock had a trading volume of 704,356 shares, compared to its average volume of 1,169,740. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a twelve month low of $42.21 and a twelve month high of $75.97. The company has a fifty day moving average price of $68.19 and a two-hundred day moving average price of $65.80. The firm has a market cap of $17.33 billion, a P/E ratio of 85.97, a PEG ratio of 1.52 and a beta of 0.72.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. During the same period in the previous year, the company posted $0.32 earnings per share. The company's revenue for the quarter was up 20.5% on a year-over-year basis. As a group, analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty's payout ratio is 57.14%.
A number of equities analysts have weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating for the company in a research note on Tuesday. BMO Capital Markets raised shares of Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Barclays lifted their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research report on Thursday, November 21st. Bank of America raised their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an "overweight" rating and a $90.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $74.40.
Check Out Our Latest Report on RYAN
Several hedge funds have recently bought and sold shares of RYAN. Hollencrest Capital Management acquired a new stake in shares of Ryan Specialty during the third quarter worth $25,000. Assetmark Inc. bought a new position in Ryan Specialty during the 3rd quarter worth about $34,000. Quarry LP raised its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock valued at $83,000 after purchasing an additional 644 shares in the last quarter. Finally, Signaturefd LLC boosted its position in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company's stock worth $89,000 after buying an additional 148 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.